EUVIMEDEUVIMED entdecken
Crossref

Non-VKA Oral Anticoagulants in Adult Congenital Heart Disease: a Single-Center Study

Pedro Garcia Brás iD, Tânia Branco Mano, Tiago Rito, Alexandra Castelo, Vera Ferreira, Ana Agapito, Rui Cruz Ferreira, Fatima Pinto, Lídia de Sousa

Cardiovascular Drugs and Therapy · 2023-12 · 37 (6) · 1077-1086

DOI: 10.1007/s10557-022-07357-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 17.06.2022. Verfasst von Pedro Garcia Brás und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Santa Marta Hospital, Centro Hospitalar Universitário de Lisboa Central, Rua de Santa Marta, n.50, 1169-024, Lisbon, Portug…. Hauptthemen laut MEDLINE: Stroke, Atrial Fibrillation, Heart Defects, Congenital, Thromboembolism. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Non-VKA oral anticoagulants (NOACs) prescription is increasing in adults with congenital heart disease (ACHD). However, data on efficacy and safety in ACHD is unclear, particularly in severe CHD. The study aimed to review the safety and efficacy of NOACs in ACHD. METHODS: Retrospective evaluation of ACHD patients started on NOACs from 2014 to 2020, with the primary endpoints of bleeding or thromboembolic events (TE). CHA2DS2-VASc and HAS-BLED scores were calculated, mortality was assessed, and risk factors for bleeding were identified. RESULTS: A total of 93 patients were included, the mean age was 52 ± 15 years, 58% were female, 55.9% had moderate CHD, and 23.7% had severe CHD (3.2% Fontan). Most (66%) had a CHA2DS2-VASc score ≥ 2 and 82% HAS-BLED ≤ 2. In a median follow-up of 41 (IQR 21) months (400.4 patient-years), there were TE in two patients. The annual risk for TE was 0.49%/patient/year. The cardiovascular mortality was 2% and all-cause mortality 5%; there were no fatal TE or bleeding events. Minor (n = 6, 6.5%) and major (n = 3, 3.2%) bleeding events were observed, a median of 12 (IQR 15) months after starting NOAC therapy. The annual risk for bleeding was 2.2%/patient/year. Renal disease (HR 14.6 [95% CI 1.23-73.6], p = 0.033) and the HAS-BLED score were predictors of major (adjusted HR 6.97 [95% CI 1.69-28.78], p = 0.007) and minor (adjusted HR 3.80 [95% CI 1.48-9.78], p = 0.006) bleeding complications. CONCLUSION: In this real-life cohort of selected ACHD, the use of NOACs was safe and effective, with a low incidence of bleeding events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeAtrial FibrillationHeart Defects, CongenitalThromboembolismHumansAdultFemaleMiddle AgedAgedMaleAnticoagulantsAdministration, OralRetrospective StudiesHemorrhage

Stichwörter der Autor:innen

Adult congenital heart diseaseAntithrombotic therapyNOACsNon-VKA oral anticoagulants

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Cardiology, Santa Marta Hospital, Centro Hospitalar Universitário de Lisboa Central, Rua de Santa Marta, n.50, 1169-024, Lisbon, Portugal. pedrobras3@gmail.com.
  • Department of Cardiology, Santa Marta Hospital, Centro Hospitalar Universitário de Lisboa Central, Rua de Santa Marta, n.50, 1169-024, Lisbon, Portugal.
  • Department of Pediatric Cardiology, Santa Marta Hospital, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.

ORCID-Profile: Pedro Garcia Brás

Zitieren

APA

Brás, P. G., Mano, T. B., Rito, T., Castelo, A., Ferreira, V., Agapito, A., Ferreira, R. C., Pinto, F., & de Sousa, L. (2023). Non-VKA Oral Anticoagulants in Adult Congenital Heart Disease: a Single-Center Study. Cardiovascular Drugs and Therapy, 37(6), 1077-1086. https://doi.org/10.1007/s10557-022-07357-5

Vancouver

Brás PG, Mano TB, Rito T, Castelo A, Ferreira V, Agapito A, et al. Non-VKA Oral Anticoagulants in Adult Congenital Heart Disease: a Single-Center Study. Cardiovascular Drugs and Therapy. 2023;37(6):1077-1086. doi:10.1007/s10557-022-07357-5

BibTeX
@article{Brs2023,
  author = {Brás, Pedro Garcia and Mano, Tânia Branco and Rito, Tiago and Castelo, Alexandra and Ferreira, Vera and Agapito, Ana and Ferreira, Rui Cruz and Pinto, Fatima and de Sousa, Lídia},
  title = {Non-VKA Oral Anticoagulants in Adult Congenital Heart Disease: a Single-Center Study},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2023},
  volume = {37},
  number = {6},
  pages = {1077--1086},
  doi = {10.1007/s10557-022-07357-5}
}
Kostenlos starten →